UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044573
Receipt number R000050915
Scientific Title Exploring epigenetic anti-cancer agents from oriental traditional medicines and elucidation of their mechanism
Date of disclosure of the study information 2021/06/25
Last modified on 2021/06/17 11:53:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploring epigenetic anti-cancer agents from oriental traditional medicines and elucidation of their mechanism

Acronym

Exploring epigenetic anti-cancer agents from oriental traditional medicines and elucidation of their mechanism

Scientific Title

Exploring epigenetic anti-cancer agents from oriental traditional medicines and elucidation of their mechanism

Scientific Title:Acronym

Exploring epigenetic anti-cancer agents from oriental traditional medicines and elucidation of their mechanism

Region

Japan


Condition

Condition

healthy volunteer

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The purpose of this study is to search for antitumor agents with epigenome molecule targets from oriental traditional medicines through bioinformatic analyses and to construct a safe and clinically applicable cancer treatment strategy.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Ex vivo cell proliferation assays are performed on peripheral blood mononuclear cells of healthy volunteers.

Key secondary outcomes

If necessary, using peripheral blood mononuclear cell samples treated with drugs, changes in gene expression, histone modification and open chromatin regions will be assesed by RNA-seq, ChIP-seq and ATAC-seq.


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Age: 20 years and over
2) Agreement to a doctor's interview regarding health condition.
3) Systolic blood pressure is 90-160 mmHg and diastolic blood pressure is 100 mmHg or less
4) Weight: men 45 kg or more, women 40 kg or more
5) After receiving sufficient explanation for participation in this study, written consent by free will have been obtained with sufficient understanding

Key exclusion criteria

1) There is a disease that requires treatment, or the patient is under examination due to suspicion of the disease.
2) Have a history of blood disorders
3) History of blood transfusion or history of organ transplantation
4) Pregnant or within 1 year of delivery
5) History of the following infectious diseases
(A) Malaria, Toxoplasma
(B) Tuberculosis within 5 years after healing
(C) Sexually transmitted diseases within 1 year after healing
(D) Dengue fever within 1 month after healing
(E) Onset of erythema infectiosum in the person within 6 months after healing or onset in the family within 1 month
6) Anyone judged inappropriate by the doctor

Target sample size



Research contact person

Name of lead principal investigator

1st name Yoshiro
Middle name
Last name Hirasaki

Organization

Graduate School of Medicine, Chiba university

Division name

Department of Japanese-Oriental (Kampo) Medicine

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba

TEL

043-226-2984

Email

hrskyshr@chiba-u.jp


Public contact

Name of contact person

1st name Yoshiro
Middle name
Last name Hirasaki

Organization

Graduate School of Medicine, Chiba university

Division name

Department of Japanese-Oriental (Kampo) Medicine

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba

TEL

043-226-2984

Homepage URL


Email

hrskyshr@chiba-u.jp


Sponsor or person

Institute

Chiba university

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Japanese-Oriental(Kampo) Medicine, Graduate School of Medicine, Chiba university

Address

1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan

Tel

0432262984

Email

hrskyshr@chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 04 Month 20 Day

Date of IRB

2020 Year 04 Month 20 Day

Anticipated trial start date

2020 Year 04 Month 20 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Ex vivo studies using blood samples collected from healthy volunteers


Management information

Registered date

2021 Year 06 Month 17 Day

Last modified on

2021 Year 06 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050915


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name